Gene · 7314
Papers1,451
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,451
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| New insights into the role of mitophagy related gene affecting the metastasis of osteosarcoma through scRNA-seq and CRISPR-Cas9 genome editing. | Cell Commun Signal | 2024 | 39696352 | PubTator, text mining | PubMed |
| c-Triadem: A constrained, explainable deep learning model to identify novel biomarkers in Alzheimer's disease. | medRxiv | 2024 | 39606415 | PubTator, text mining | PubMed |
| Dung beetle optimization algorithm-based hybrid deep learning model for ultra-short-term PV power prediction. | iScience | 2024 | 39524344 | PubTator, text mining | PubMed |
Diminished expression of the ubiquitin-proteasome system in early treatment-naïve patients with rheumatoid arthritis and concomitant type 2 diabetes may be linked to IL-1 pathway hyper-activity; results from PEAC cohort. | Arthritis Res Ther | 2024 | 39342401 | PubTator, text mining | PubMed |
| Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals ubiquitin promotes pulmonary fibrosis in chronic pulmonary diseases. | Sci Rep | 2024 | 39261509 | PubTator, text mining | PubMed |
| Bioinformatic analysis of hippocampal histopathology in Alzheimer's disease and the therapeutic effects of active components of traditional Chinese medicine. | Front Pharmacol | 2024 | 39221152 | PubTator, text mining | PubMed |
| Ubiquitin's Conformational Heterogeneity as Discerned by Nuclear Magnetic Resonance Spectroscopy. | Chembiochem | 2024 | 39140844 | PubTator, text mining | PubMed |
| Mitophagy and clear cell renal cell carcinoma: insights from single-cell and spatial transcriptomics analysis. | Front Immunol | 2024 | 38994370 | PubTator, text mining | PubMed |
| Validating the temporal performance of genetic biomarkers in an animal model of recurrence/ non-recurrence myocardial infarction persuades by bioinformatics tools. | Eur J Pharmacol | 2024 | 38950836 | PubTator, text mining | PubMed |
| Identification of biomarkers related to angiogenesis in myocardial ischemia-reperfusion injury and prediction of potential drugs. | PLoS One | 2024 | 38935597 | PubTator, text mining | PubMed |
| PredGCN: a Pruning-enabled Gene-Cell Net for automatic cell annotation of single cell transcriptome data. | Bioinformatics | 2024 | 38924517 | PubTator, text mining | PubMed |
| Unveiling shared biomarkers and therapeutic targets between systemic lupus erythematosus and heart failure through bioinformatics analysis. | Front Med (Lausanne) | 2024 | 38912340 | PubTator, text mining | PubMed |
| Normal Mode Analysis Elicits Conformational Shifts in Proteins at Both Proximal and Distal Regions to the Phosphosite Stemming from Single-Site Phosphorylation. | ACS Omega | 2024 | 38882086 | PubTator, text mining | PubMed |
| Loss of the proteasomal deubiquitinase USP14 induces growth defects and a senescence phenotype in colorectal cancer cells. | Sci Rep | 2024 | 38844605 | PubTator, text mining | PubMed |
| Gene signatures of endoplasmic reticulum stress and mitophagy for prognostic risk prediction in lung adenocarcinoma. | IET Syst Biol | 2024 | 38813617 | PubTator, text mining | PubMed |
| Disregarding multimappers leads to biases in the functional assessment of NGS data. | BMC Genomics | 2024 | 38720252 | PubTator, text mining | PubMed |
| Anti-Cancer Mechanisms of Diarylpentanoid MS17 (1,5-Bis(2-hydroxyphenyl)-1,4-pentadiene-3-one) in Human Colon Cancer Cells: A Proteomics Approach. | Int J Mol Sci | 2024 | 38542474 | PubTator, text mining | PubMed |
| Identification and validation of mitophagy-related signatures as a novel prognostic model for colorectal cancer. | Transl Cancer Res | 2024 | 38482399 | PubTator, text mining | PubMed |
| Ubiquitin B, Ubiquitin C, and β-Catenin as Promising Diagnostic and Prognostic Tools in Prostate Cancer. | Cancers (Basel) | 2024 | 38473264 | PubTator, text mining | PubMed |
| Downregulation of UBB potentiates SP1/VEGFA-dependent angiogenesis in clear cell renal cell carcinoma. | Oncogene | 2024 | 38467852 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7314/papers?page=3